Organon & Co.
OGN | NYSE
$13.83
-$0.01 (-0.07%)
Nov 2, 2026, 3:55 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 6.22B | 6.4B | 6.26B | 6.17B | 6.3B | 6.53B |
Cost of Revenue | 2.85B | 2.69B | 2.52B | 2.29B | 2.38B | 2.12B |
Gross Profit | 3.36B | 3.72B | 3.75B | 3.88B | 3.92B | 4.41B |
Operating Income | 1.29B | 1.49B | 1.33B | 1.71B | 1.92B | 2.85B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 425M | 807M | 673M | 1.12B | 1.53B | 2.75B |
Net Income | 187M | 864M | 1.02B | 917M | 1.35B | 2.16B |
Selling & General & Admin | 1.71B | 1.76B | 1.89B | 1.7B | 1.67B | 1.36B |
Research & Development | 366M | 469M | 528M | 471M | 443M | 210M |
Other Expenses | 10M | n/a | n/a | n/a | -104M | n/a |
Operating Expenses | 2.09B | 2.23B | 2.42B | 2.18B | 2.01B | 1.57B |
Interest Expense | 504M | 520M | 527M | 422M | 258M | 6M |
Selling & Marketing Expenses | n/a | 206M | 209M | 255M | 236M | 198M |
Cost & Expenses | 4.93B | 4.92B | 4.94B | 4.47B | 4.39B | 3.69B |
Income Tax Expense | 238M | -57M | -350M | 205M | 178M | 496M |
Shares Outstanding (Basic) | 259.5M | 257.05M | 255.24M | 254.08M | 253.55M | 253.52M |
Shares Outstanding (Diluted) | 260.76M | 259.15M | 256.27M | 255.17M | 253.55M | 253.52M |
EPS (Basic) | 0.72 | 3.36 | 4.01 | 3.61 | 5.33 | 8.52 |
EPS (Diluted) | 0.72 | 3.33 | 3.99 | 3.59 | 5.33 | 8.52 |
EBITDA | 1.29B | 1.6B | 1.44B | 1.76B | 1.98B | 2.99B |
EBIT | 929M | 1.33B | 1.2B | 1.54B | 1.79B | 2.85B |
Depreciation & Amortization | 361M | 277M | 236M | 212M | 195M | 142M |
Add to Watchlist
Select watchlists to add or remove OGN